This compound is a chiral pharmaceutical intermediate featuring a tetrahydrofuran ring substituted with a difluoromethoxyphenyl group and multiple fluorine atoms. Its stereochemistry is defined, making it suitable for use in the synthesis of enantiomerically pure active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2649470-87-9
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt
research reagent
N-Carbobenzyloxy-L-glutamine
pharmaceutical intermediate
(S)-(+)-1-Methoxy-2-propanol
pharmaceutical intermediate
3-amino-N-(4-aminophenyl)benzamide
pharmaceutical intermediate
5-(acetoacetylamino)benzimidazolone
pharmaceutical intermediate
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
pharmaceutical raw material
Suzetrigine Impurity 4
pharmaceutical raw material
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carboxylic acid
HMJBDIINGXHMMN-BEWJGFNTSA-N
C[C@H]1[C@H]([C@@H](O[C@@]1(C)C(F)(F)F)C(=O)O)C2=C(C(=C(C=C2)F)F)OC